Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $107.25
-
Support level$103.14
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)37.6
- With a 51.3 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$63.15 | $117.41 | 85.4% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$89.15 | $107.08 | $110.75 | $110.17 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.4%
-
In the next month14.5%
-
In the next year45.7%
Period | Value |
---|---|
Historical (5 year) | 26.2% |
Last month | 29.7% |
Current estimate | 23.7% |
Next month forecast | 25.6% |